Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The effect of cell therapy with NGF on CSF cholinergic biomarkers in ten patients with Alzheimer´s disease

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: KARAMI, Azadeh (Karolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Stockholm, Sweden)
  • Co-author(s): Azadeh Karami: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Helga Eyjólfsdóttir: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Swetha Vijayaraghavana: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Ahmadul Kadir: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Bengt Linderoth: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden
    Göran Lind: Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden;Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
    Niels Andreasen: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden
    Anders Wall: Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
    Åke Seiger: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Per Almqvist: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden
    Lars Wahlberg: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;, NsGene A/S, Ballerup, Denmark
    Agneta Nordberg: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden
    Taher Darreh-Shori: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Maria Eriksdotter: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden
  • Abstract:

    Backgrounds

    Alzheimer’s disease (AD) is a progressive disease and the most common form of dementia with extensive loss of central cholinergic functions and a gradual decline in cognition and memory. Animal studies indicate that nerve growth factor (NGF) improves cholinergic functions, memory and cognitive behaviors. In addition, we have recently..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses